<DOC>
	<DOCNO>NCT02833467</DOCNO>
	<brief_summary>Targeted next generation sequencing ( NGS ) provide promising method diagnostic purpose enable simultaneous detection multiple gene mutation . This study evaluate feasibility application value use NGS identify genomic mutation multiple multifocal primary lung cancer cell-tumor DNA ( ctDNA ) surgical patient</brief_summary>
	<brief_title>Identifying Genomic Mutations Multiple Primary Lung Cancers Circulating Tumor DNA</brief_title>
	<detailed_description>Tumor sample originate clinically consider multiple multifocal primary lung cancer patient available mutational analysis . DNA RNA extract fresh tumor tissue formalin-fixed , paraffin-embedded ( FFPE ) tissue . A series cancer-related genomic alteration include single nucleotide variation ( SNVs ) , short insertion deletion ( InDels ) , copy number variation ( CNVs ) gene rearrangement identify Oncomine Comprehensive Panel ( OCP ) . High frequency mutation also identify blood sample droplet digital polymerase chain reaction ( ddPCR ) .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Thoracic Neoplasms</mesh_term>
	<criteria>Patients must give write informed consent Histopathologically confirm NSCLC Considered multiple multifocal primary lung cancer clinical criterion Malignant tumor history within past 5 year Patients receive treatment prior resection Insufficient tumor tissue blood sample</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Circulating Tumor DNA</keyword>
	<keyword>Heterogeneous</keyword>
	<keyword>Multiple primary lung cancer</keyword>
</DOC>